News

Company News & Events

Oryzon to present at upcoming international conferences

9 April 2018

MADRID, SPAIN and CAMBRIDGE MA.

• HC Wainwright Global Life Sciences Conference - 2018, Monaco

• AACR Annual Meeting 2018, Chicago, Illinois, United States

• 13th edition of the European Smallcap Event, Paris, France

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences.

 

Click here to see the full Press Release

 

Posted In: 
News
Investors

Share this story